RIGEL PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Rigel Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Rigel Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 17.6M shares, a 89.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 17.6M -157M -89.9% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 17.6M -157M -89.9% Aug 1, 2024 10-Q 2024-08-06
Q1 2024 175M +1.74M +1% May 2, 2024 10-Q 2024-05-07
Q3 2023 174M +1.53M +0.89% Nov 2, 2023 10-Q 2023-11-07
Q2 2023 174M +1.53M +0.88% Jul 27, 2023 10-Q 2023-08-01
Q1 2023 174M +1.61M +0.94% Apr 27, 2023 10-Q 2023-05-02
Q3 2022 173M +1.83M +1.07% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 173M +1.99M +1.16% Jul 29, 2022 10-Q 2022-08-02
Q1 2022 172M +1.89M +1.11% Apr 29, 2022 10-Q 2022-05-03
Q3 2021 171M +2.02M +1.2% Oct 29, 2021 10-Q 2021-11-02
Q2 2021 171M +1.92M +1.14% Jul 30, 2021 10-Q 2021-08-03
Q1 2021 170M +1.59M +0.95% Apr 30, 2021 10-Q 2021-05-05
Q3 2020 169M +1.37M +0.82% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 169M +1.32M +0.79% Aug 1, 2020 10-Q 2020-08-04
Q1 2020 169M +1.38M +0.82% May 1, 2020 10-Q 2020-05-05
Q3 2019 168M +970K +0.58% Nov 1, 2019 10-Q 2019-11-05
Q2 2019 168M +1.17M +0.7% Aug 1, 2019 10-Q 2019-08-06
Q1 2019 167M +3.61M +2.21% May 1, 2019 10-Q 2019-05-07
Q3 2018 167M +20.1M +13.8% Nov 1, 2018 10-Q 2018-11-06
Q2 2018 166M +42.1M +33.8% Aug 2, 2018 10-Q 2018-08-08
Q1 2018 164M +41.1M +33.6% Apr 26, 2018 10-Q 2018-05-01
Q3 2017 146M +47.6M +48.1% Nov 1, 2017 10-Q 2017-11-07
Q2 2017 124M +29.8M +31.5% Jul 26, 2017 10-Q 2017-08-01
Q1 2017 122M +30.3M +32.9% Apr 26, 2017 10-Q 2017-05-02
Q3 2016 98.9M +10.4M +11.8% Oct 26, 2016 10-Q 2016-11-01
Q2 2016 94.6M +6.09M +6.88% Jul 27, 2016 10-Q 2016-08-02
Q1 2016 92.1M +4M +4.54% Apr 28, 2016 10-Q 2016-05-03
Q3 2015 88.5M +733K +0.84% Oct 29, 2015 10-Q 2015-11-03
Q2 2015 88.5M +711K +0.81% Jul 30, 2015 10-Q 2015-08-04
Q1 2015 88.1M +613K +0.7% May 4, 2015 10-Q 2015-05-07
Q3 2014 87.8M +362K +0.41% Oct 29, 2014 10-Q 2014-11-04
Q2 2014 87.8M +362K +0.41% Jul 30, 2014 10-Q 2014-08-05
Q1 2014 87.5M +391K +0.45% Apr 30, 2014 10-Q 2014-05-07
Q3 2013 87.4M +430K +0.49% Oct 30, 2013 10-Q 2013-11-05
Q2 2013 87.4M +15.8M +22.1% Jul 31, 2013 10-Q 2013-08-06
Q1 2013 87.1M +15.7M +22% May 1, 2013 10-Q 2013-05-07
Q3 2012 87M +15.8M +22.1% Oct 31, 2012 10-Q 2012-11-06
Q2 2012 71.6M +403K +0.57% Aug 2, 2012 10-Q 2012-08-07
Q1 2012 71.5M Apr 25, 2012 10-Q 2012-05-01
Q3 2011 71.2M Oct 26, 2011 10-Q 2011-11-01
Q2 2011 71.2M Jul 27, 2011 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.